Follow the people · Insider
Robert Baltera Jr.
Robert Baltera Jr. files insider transactions with the SEC as a director of Palisade Bio (PALI). We hold 6 disclosed purchases and sales filed since 7 September 2012, 6 of them in the last 90 days.
- Files forPALI
- Disclosed buys and sells6 in all, 6 in the last 90 days
- Last disclosure10 July 2026
Positions held
5 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 10 June 2026 — 9 July 2026Director · Palisade Bio (PALI)7 Form 4 lines · source: SEC Form 4
- Filed 15 July 2021 — 11 January 2023Director · Imago BioSciences (IMGO)7 Form 4 lines · source: SEC Form 4
- Filed 22 November 2022 — 22 November 2022Director · Frazier Lifesciences Acquisition (FLAC)1 Form 4 line · source: SEC Form 4
- Filed 5 September 2012 — 26 July 2018Director · Organovo Holdings (ONVO)16 Form 4 lines · source: SEC Form 4
- Filed 12 June 2014 — 23 June 2016Director · Xencor (XNCR)3 Form 4 lines · source: SEC Form 4
Everything they disclosed
34 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 20,000 shares of Palisade BioSEC Form 410 July 2026Common Stock · traded 8 July 2026 · filed 10 July 2026
- ▲ bought on the open market 25,000 shares of Palisade BioSEC Form 410 July 2026Common Stock · traded 9 July 2026 · filed 10 July 2026
- ▲ bought on the open market 20,000 shares of Palisade BioSEC Form 48 July 2026Common Stock · traded 6 July 2026 · filed 8 July 2026
- ▲ bought on the open market 30,000 shares of Palisade BioSEC Form 48 July 2026Common Stock · traded 7 July 2026 · filed 8 July 2026
- ▲ bought on the open market 20,000 shares of Palisade BioSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- ▲ bought on the open market 10,000 shares of Palisade BioSEC Form 46 July 2026Common Stock · traded 2 July 2026 · filed 6 July 2026
- was granted 336,904 shares of Palisade BioSEC Form 418 June 2026Common Stock · traded 10 June 2026 · filed 18 June 2026
- returned to the issuer 114,075 shares of Imago BioSciences (a derivative holding)SEC Form 411 January 2023Stock Option (Right to Buy) · traded 11 January 2023 · filed 11 January 2023
- returned to the issuer 23,809 shares of Imago BioSciences (a derivative holding)SEC Form 411 January 2023Stock Option (Right to Buy) · traded 11 January 2023 · filed 11 January 2023
- returned to the issuer 11,904 shares of Imago BioSciences (a derivative holding)SEC Form 411 January 2023Stock Option (Right to Buy) · traded 11 January 2023 · filed 11 January 2023
- disposed of in a tender offer 850 shares of Imago BioSciencesSEC Form 411 January 2023Common Stock · traded 11 January 2023 · filed 11 January 2023
- exercised options over 30,000 shares of Frazier Lifesciences Acquisition (a derivative holding)SEC Form 423 November 2022Class B Ordinary Shares · traded 22 November 2022 · filed 23 November 2022
- was granted 11,904 shares of Imago BioSciences (a derivative holding)SEC Form 43 June 2022Stock Option (Right to Buy) · traded 1 June 2022 · filed 3 June 2022
- ▲ bought on the open market 850 shares of Imago BioSciencesSEC Form 419 July 2021Common Stock · traded 15 July 2021 · filed 19 July 2021
- was granted 23,809 shares of Imago BioSciences (a derivative holding)SEC Form 419 July 2021Stock Option (Right to Buy) · traded 15 July 2021 · filed 19 July 2021
- was granted 45,500 shares of Organovo Holdings (a derivative holding)SEC Form 430 July 2018Stock Option (Right to Buy) · traded 26 July 2018 · filed 30 July 2018
- was granted 42,500 shares of Organovo Holdings (a derivative holding)SEC Form 428 August 2017Stock Option (Right to Buy) · traded 24 August 2017 · filed 28 August 2017
- was granted 7,500 shares of Organovo HoldingsSEC Form 419 August 2016Common Stock · traded 17 August 2016 · filed 19 August 2016
- was granted 18,500 shares of Organovo Holdings (a derivative holding)SEC Form 419 August 2016Stock Option (Right to Buy) · traded 17 August 2016 · filed 19 August 2016
- was granted 7,500 shares of Xencor (a derivative holding)SEC Form 48 July 2016Stock Option (Right to Buy) · traded 23 June 2016 · filed 8 July 2016
- ▼ sold on the open market 6,000 shares of Organovo HoldingsSEC Form 423 September 2015Common Stock · traded 21 September 2015 · filed 23 September 2015
- was granted 37,000 shares of Organovo Holdings (a derivative holding)SEC Form 424 August 2015Stock Option (Right to Buy) · traded 20 August 2015 · filed 24 August 2015
- was granted 7,500 shares of Xencor (a derivative holding)SEC Form 411 June 2015Stock Option (Right to Buy) · traded 9 June 2015 · filed 11 June 2015
- was granted 31,500 shares of Organovo Holdings (a derivative holding)SEC Form 426 August 2014Stock Option (Right to Buy) · traded 20 August 2014 · filed 26 August 2014
- was granted 7,500 shares of Xencor (a derivative holding)SEC Form 416 June 2014Stock Option (Right to Buy) · traded 12 June 2014 · filed 16 June 2014
- exercised in-the-money options over 3,000 shares of Organovo HoldingsSEC Form 49 June 2014Common Stock · traded 6 June 2014 · filed 9 June 2014
- exercised in-the-money options over 3,000 shares of Organovo Holdings (a derivative holding)SEC Form 49 June 2014Warrant (Right to Buy) · traded 6 June 2014 · filed 9 June 2014
- was granted 30,500 shares of Organovo Holdings (a derivative holding)SEC Form 423 August 2013Stock Option (Right to Buy) · traded 21 August 2013 · filed 23 August 2013
- filed a transaction coded H in 25,000 shares of Organovo Holdings (a derivative holding)SEC Form 421 December 2012Warrant (Right to Buy) · traded 21 December 2012 · filed 21 December 2012
- ▲ bought on the open market 25,000 shares of Organovo Holdings (a derivative holding)SEC Form 421 December 2012Warrant (Right to Buy) · traded 21 December 2012 · filed 21 December 2012
- exercised options over 25,000 shares of Organovo Holdings (a derivative holding)SEC Form 421 December 2012Warrant (Right to Buy) · traded 21 December 2012 · filed 21 December 2012
- exercised options over 25,000 shares of Organovo HoldingsSEC Form 421 December 2012Common Stock · traded 21 December 2012 · filed 21 December 2012
- was granted 17,500 shares of Organovo Holdings (a derivative holding)SEC Form 422 October 2012Stock Option (Right to Buy) · traded 18 October 2012 · filed 22 October 2012
- was granted 31,500 shares of Organovo Holdings (a derivative holding)SEC Form 47 September 2012Stock Option (Right to Buy) · traded 5 September 2012 · filed 7 September 2012
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.